Turkey tail mushroom

Last Updated: September 28 2022

Turkey Tail Mushroom (Trametes versicolor) is a mushroom that is a source of a polysaccharide, known as polysaccharide K, that is established as a cancer adjunct therapy for the immune system.

Turkey tail mushroom is most often used for

What else is Turkey tail mushroom known as?
Note that Turkey tail mushroom is also known as:
  • Turkey Tail Mushroom
  • Coriolus Versicolor
  • Polyporus Versicolor
  • Trametes Versicolor
Examine Database: Turkey tail mushroom
What works and what doesn't?

Unlock the full potential of Examine

Get started

Don't miss out on the latest research

3.^Sakagami H, Sugaya K, Utsumi A, Fujinaga S, Sato T, Takeda MStimulation by PSK of interleukin-1 production by human peripheral blood mononuclear cellsAnticancer Res.(1993 May-Jun)
4.^Zaidman BZ, Yassin M, Mahajna J, Wasser SPMedicinal mushroom modulators of molecular targets as cancer therapeuticsAppl Microbiol Biotechnol.(2005 Jun)
7.^Kato M, Hirose K, Hakozaki M, Ohno M, Saito Y, Izutani R, Noguchi J, Hori Y, Okumoto S, Kuroda D, et alInduction of gene expression for immunomodulating cytokines in peripheral blood mononuclear cells in response to orally administered PSK, an immunomodulating protein-bound polysaccharideCancer Immunol Immunother.(1995 Mar)
8.^Lu H, Yang Y, Gad E, Wenner CA, Chang A, Larson ER, Dang Y, Martzen M, Standish LJ, Disis MLPolysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cellsClin Cancer Res.(2011 Jan 1)
9.^Azuma M, Sawahata R, Akao Y, Ebihara T, Yamazaki S, Matsumoto M, Hashimoto M, Fukase K, Fujimoto Y, Seya TThe peptide sequence of diacyl lipopeptides determines dendritic cell TLR2-mediated NK activationPLoS One.(2010 Sep 2)
11.^Torkelson CJ, Sweet E, Martzen MR, Sasagawa M, Wenner CA, Gay J, Putiri A, Standish LJPhase 1 Clinical Trial of Trametes versicolor in Women with Breast CancerISRN Oncol.(2012)
13.^Lu H, Yang Y, Gad E, Inatsuka C, Wenner CA, Disis ML, Standish LJTLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapyClin Cancer Res.(2011 Nov 1)
14.^Moreno M, Mol BM, von Mensdorff-Pouilly S, Verheijen RH, von Blomberg BM, van den Eertwegh AJ, Scheper RJ, Bontkes HJToll-like receptor agonists and invariant natural killer T-cells enhance antibody-dependent cell-mediated cytotoxicity (ADCC)Cancer Lett.(2008 Dec 8)